Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 1/2021

14-05-2020 | Letter to the Editor

Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?

Auteurs: Amelle Shillington, Martine Lamy, Marissa Vawter-Lee, Craig Erickson, Howard Saal, Davide Comoletti, Katherine Abell

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 1/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Excerpt

Autism Spectrum Disorder (ASD) is a developmental disorder characterized by impairments in social communication along with restrictive interests and repetitive behaviors that are typically present early in development. Genetics has a key role in the etiology of ASD, while environmental factors interplay at the molecular level contributing to changes in neuronal development, growth of the brain, and synaptic connectivity. Genes responsible for protein function within synapses are of particular interest in the pathology of ASD. Imbalances in excitatory-inhibitory signaling at the synaptic level are thought to contribute to destabilization of neural processing early in development leading to the ASD phenotype (Howell and Smith 2019). Neurexins and neuroligins are two families of transmembrane synaptic cell adhesion molecule (SCAM) proteins located at presynaptic and postsynaptic membranes respectively. These proteins function to induce synapse formation and maturation. SH3 and multiple ankyrin repeat domains (SHANK) proteins (SHANK1, SHANK2, SHANK3) indirectly tether SCAM proteins and glutamate receptor proteins (Fig. 1a, b) creating a functional complex necessary for optimal synaptic signaling (Howell and Smith 2019). Variants in genes in these pathways have been linked to ASD (Cao and Tabuchi 2017) and SCAM and SHANK knock-out mice models show autistic behavioral phenotypes (Baig et al. 2017).
Literatuur
go back to reference Baig, D. N., Yanagawa, T., & Tabuchi, K. (2017). Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders. Brain Research Bulletin, 129, 82–90.CrossRef Baig, D. N., Yanagawa, T., & Tabuchi, K. (2017). Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders. Brain Research Bulletin, 129, 82–90.CrossRef
go back to reference Belligni, E. F., Di Gregorio, E., Biamino, E., Calcia, A., Molinatto, C., Talarico, F., et al. (2012). 790 Kb microduplication in chromosome band 17p13. 1 associated with intellectual disability, afebrile seizures, dysmorphic features, diabetes, and hypothyroidism. European Journal of Medical Genetics, 55(3), 222–224.CrossRef Belligni, E. F., Di Gregorio, E., Biamino, E., Calcia, A., Molinatto, C., Talarico, F., et al. (2012). 790 Kb microduplication in chromosome band 17p13. 1 associated with intellectual disability, afebrile seizures, dysmorphic features, diabetes, and hypothyroidism. European Journal of Medical Genetics, 55(3), 222–224.CrossRef
go back to reference Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., et al. (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature Genetics, 42(6), 489.CrossRef Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., et al. (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature Genetics, 42(6), 489.CrossRef
go back to reference Breckpot, J., Vercruyssen, M., Weyts, E., Vandevoort, S., D'Haenens, G., Van Buggenhout, G., et al. (2016). Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. European Journal of Medical Genetics, 59(9), 436–443.CrossRef Breckpot, J., Vercruyssen, M., Weyts, E., Vandevoort, S., D'Haenens, G., Van Buggenhout, G., et al. (2016). Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. European Journal of Medical Genetics, 59(9), 436–443.CrossRef
go back to reference Cao, X., & Tabuchi, K. (2017). Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders. Neuroscience Research, 116, 3–9.CrossRef Cao, X., & Tabuchi, K. (2017). Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders. Neuroscience Research, 116, 3–9.CrossRef
go back to reference Dong, H., Sharma, M., Zhou, H. X., & Cross, T. A. (2012). Glycines: Role in α-helical membrane protein structures and a potential indicator of native conformation. Biochemistry, 51(24), 4779–4789.CrossRef Dong, H., Sharma, M., Zhou, H. X., & Cross, T. A. (2012). Glycines: Role in α-helical membrane protein structures and a potential indicator of native conformation. Biochemistry, 51(24), 4779–4789.CrossRef
go back to reference Egger, J. I., Verhoeven, W. M., Groenendijk-Reijenga, R., & Kant, S. G. (2017). Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: Successful treatment with lithium. Case Reports, 2017, bcr-2017. Egger, J. I., Verhoeven, W. M., Groenendijk-Reijenga, R., & Kant, S. G. (2017). Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: Successful treatment with lithium. Case Reports, 2017, bcr-2017.
go back to reference Ellul, P., & Choucha, W. (2015). Neurobiological approach of catatonia and treatment perspectives. Frontiers in Psychiatry, 6, 182.CrossRef Ellul, P., & Choucha, W. (2015). Neurobiological approach of catatonia and treatment perspectives. Frontiers in Psychiatry, 6, 182.CrossRef
go back to reference Hare, D. J., & Malone, C. (2004). Catatonia and autistic spectrum disorders. Autism, 8(2), 183–195.CrossRef Hare, D. J., & Malone, C. (2004). Catatonia and autistic spectrum disorders. Autism, 8(2), 183–195.CrossRef
go back to reference Howell, B. W., & Smith, K. M. (2019). Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder. Pharmacological Research, 139, 207–214.CrossRef Howell, B. W., & Smith, K. M. (2019). Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder. Pharmacological Research, 139, 207–214.CrossRef
go back to reference Kuroda, Y., Ohashi, I., Tominaga, M., Saito, T., Nagai, J. I., Ida, K., et al. (2014). De novo duplication of 17p13. 1–p13. 2 in a patient with intellectual disability and obesity. American Journal of Medical Genetics Part A, 164(6), 1550–1554.CrossRef Kuroda, Y., Ohashi, I., Tominaga, M., Saito, T., Nagai, J. I., Ida, K., et al. (2014). De novo duplication of 17p13. 1–p13. 2 in a patient with intellectual disability and obesity. American Journal of Medical Genetics Part A, 164(6), 1550–1554.CrossRef
go back to reference Mooneyham, K. A., Holden, K. R., Cathey, S., Dwivedi, A., Dupont, B. R., & Lyons, M. J. (2014). Neurodevelopmental delays and macrocephaly in 17p13. 1 microduplication syndrome. American Journal of Medical Genetics Part A, 164(11), 2887–2891.CrossRef Mooneyham, K. A., Holden, K. R., Cathey, S., Dwivedi, A., Dupont, B. R., & Lyons, M. J. (2014). Neurodevelopmental delays and macrocephaly in 17p13. 1 microduplication syndrome. American Journal of Medical Genetics Part A, 164(11), 2887–2891.CrossRef
go back to reference Parente, D. J., Garriga, C., Baskin, B., Douglas, G., Cho, M. T., Araujo, G. C., et al. (2017). Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity. American Journal of Medical Genetics Part A, 173(1), 213–216.CrossRef Parente, D. J., Garriga, C., Baskin, B., Douglas, G., Cho, M. T., Araujo, G. C., et al. (2017). Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity. American Journal of Medical Genetics Part A, 173(1), 213–216.CrossRef
go back to reference Rapoport, J., Chavez, A., Greenstein, D., Addington, A., & Gogtay, N. (2009). Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. Journal of the American Academy of Child & Adolescent Psychiatry, 48(1), 10–18.CrossRef Rapoport, J., Chavez, A., Greenstein, D., Addington, A., & Gogtay, N. (2009). Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. Journal of the American Academy of Child & Adolescent Psychiatry, 48(1), 10–18.CrossRef
go back to reference Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019). CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886–D894.CrossRef Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019). CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886–D894.CrossRef
go back to reference Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11(4), 361–362.CrossRef Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11(4), 361–362.CrossRef
go back to reference Serret, S., Thümmler, S., Dor, E., Vesperini, S., Santos, A., & Askenazy, F. (2015). Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder. BMC Psychiatry, 15(1), 107.CrossRef Serret, S., Thümmler, S., Dor, E., Vesperini, S., Santos, A., & Askenazy, F. (2015). Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder. BMC Psychiatry, 15(1), 107.CrossRef
go back to reference Walton, J. R., & Coury, D. L. (2015). Medical comorbidities in autism spectrum disorder. In Clinician’s manual on autism spectrum disorder (pp. 33–41). Adis, Cham. Walton, J. R., & Coury, D. L. (2015). Medical comorbidities in autism spectrum disorder. In Clinician’s manual on autism spectrum disorder (pp. 33–41). Adis, Cham.
go back to reference Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. The British Journal of Psychiatry, 176(4), 357–362.CrossRef Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. The British Journal of Psychiatry, 176(4), 357–362.CrossRef
go back to reference Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., et al. (2005). Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Molecular Psychiatry, 10(4), 329–332.CrossRef Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., et al. (2005). Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Molecular Psychiatry, 10(4), 329–332.CrossRef
Metagegevens
Titel
Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?
Auteurs
Amelle Shillington
Martine Lamy
Marissa Vawter-Lee
Craig Erickson
Howard Saal
Davide Comoletti
Katherine Abell
Publicatiedatum
14-05-2020
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 1/2021
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-020-04531-2

Andere artikelen Uitgave 1/2021

Journal of Autism and Developmental Disorders 1/2021 Naar de uitgave